Stay updated on Clinical Trial: Atezo + FLOT vs. FLOT in GC/GEJ
Sign up to get notified when there's something new on the Clinical Trial: Atezo + FLOT vs. FLOT in GC/GEJ page.

Latest updates to the Clinical Trial: Atezo + FLOT vs. FLOT in GC/GEJ page
- Check3 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the study page remains inaccessible with a 403 error.SummaryDifference0.2%

- Check10 days agoChange DetectedThe study record view is replaced by a 403 Forbidden message, while a sitewide NIH notice about terminology appears at the top of the page.SummaryDifference2%

- Check17 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedThe site footer’s revision indicator changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study record content. This makes the trial details temporarily inaccessible from the page.SummaryDifference21%

- Check66 days agoChange DetectedNew NIH grant/contract attribution for 2017 is now displayed on the page. The page revision tag has been updated to v3.6.6, replacing the previous v3.6.5 tag.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Atezo + FLOT vs. FLOT in GC/GEJ
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Atezo + FLOT vs. FLOT in GC/GEJ page.